SenesTech, based in Phoenix, Arizona, specializes in fertility control products for pest management, including ContraPest, which targets rat reproduction without causing illness or bait aversion. The company went public on December 8, 2016, and employs 25 full-time staff.
SenesTech (SNES) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, SenesTech's actual EPS was -$1.22, beating the estimate of -$1.53 per share, resulting in a 20.26% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.